ePro

Byrom, Bill (EDT)/ Tiplady, Brian (EDT)

Editore: Taylor & Francis, 2010
ISBN 10: 0566087715 / ISBN 13: 9780566087714
Usato / Hardcover / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Our orders are sent from our warehouse locally or directly from our international distributors to allow us to offer you the best possible price and delivery time. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
0 valutazione media
(0 valutazioni)

Riassunto: Patient self-reported data has become increasingly important in today's clinical trials. Trials in some disease indications rely upon patient recorded diary data as the primary endpoint to demonstrate drug efficacy - including, for example, indications such as insomnia, migraine and pain. In addition, improvements in quality of life measured using patient questionnaires can now be included as claims on drug labelling. Traditionally these data have been collected using paper questionnaires and diaries issued to subjects. Regulators and the industry have become increasingly aware of the limitations of recording patient reported outcomes data on paper including data quality and integrity issues. As a result there is a growing interest in collection of patient reported outcomes data using electronic means (ePRO). Solutions include handheld PDAs, Interactive Voice Response (IVR) systems, and other site-based hardware such as touchscreen PCs. Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern the community. These include: ¢ How should instruments developed on paper be adapted for electronic use, and what degree of validation should be done between paper and electronic forms? ¢ How can researchers ensure they are complying with regulatory requirements including the PRO guidance published by FDA in 2009 when using ePRO solutions? ¢ Can fewer patients be exposed in a clinical trial as a result of improved data quality obtained using electronic diaries? ¢ What type of solution should be used for certain patient populations and protocols, and how can ePRO solutions be designed optimally to increase patient acceptability and compliance? Bill Byrom and Brian Tiplady's ePro addresses all these issues, reviews the new FDA guidance, and provides a very contemporary view on this important subject.

About the Author: Bill Byrom completed his PhD in disease control simulation at Strathclyde University in 1990 and this work took him to Africa to study the effects and spread of cattle diseases. This interest led him to join the Pharmaceutical industry in 1991 where he began as a clinical trial statistician. Bill transitioned to clinical development where he became a trial director working in a number of early phase therapy areas. Before joining ClinPhone in 2000, Bill took on responsibility for the scientific content of the European market launch of a new antipsychotic agent. Throughout his clinical trials experience Bill maintained an active interest in how new technologies and methodologies could be leveraged in clinical development programmes, and so his move to Perceptive Informatics (formerly ClinPhone) in 2000 was an ideal fit. In his role as Senior Director of Product Strategy he has helped to shape a number of the company's products and services including ePRO solutions, patient recruitment technologies and RTSM (Randomization and Trial Supply Management) solutions. Bill is currently responsible for the company's eClinical strategy. Bill has authored over 60 articles in international and trade journals, and is a regular speaker on the conference circuit. Brian Tiplady, B.A., Ph.D is Senior Clinical Scientist at Pro Consulting, a division of Invivodata Inc. Brian Tiplady started in the pharmaceutical industry in 1976 as a Neuroscientist carrying out clinical research in depression and senile dementia. He later became responsible for data management and statistics, and has worked on every stage of the clinical trial process. He started working with electronic patient reported outcomes (ePRO) in 1993. He has carried out and published evaluation studies on patient use of pen-based handheld diaries and questionnaires, supported in-house projects, and worked with strategic and logistic issues involved in effectively using ePRO, and in evaluating the benefits obtained. He currently works with PRO Consulting, a division of Invivodat Inc, providing scientific support for the development and deployment of ePRO methods in clinical trials.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: ePro
Casa editrice: Taylor & Francis
Data di pubblicazione: 2010
Legatura: Hardcover
Condizione libro: New
Edizione: 1.

I migliori risultati di ricerca su AbeBooks

1.

Tiplady, Brian
Editore: Routledge (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Usato Rilegato Quantità: 2
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Routledge, 2010. Hardcover. Condizione libro: Very Good. Great condition with minimal wear, aging, or shelf wear. Codice libro della libreria P020566087715

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra usato
EUR 87,00
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 1,69
In U.S.A.
Destinazione, tempi e costi

2.

Tiplady, Brian
Editore: Routledge (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 3
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Routledge, 2010. Hardcover. Condizione libro: New. Codice libro della libreria P110566087715

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 102,33
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 1,69
In U.S.A.
Destinazione, tempi e costi

3.

Bill Byrom
Editore: Ashgate 2010-10-28, Farnham (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 5
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Ashgate 2010-10-28, Farnham, 2010. hardback. Condizione libro: New. Codice libro della libreria 9780566087714

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 108,97
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,74
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Brian Tiplady
Editore: Taylor Francis Ltd, United Kingdom (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 10
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Taylor Francis Ltd, United Kingdom, 2010. Hardback. Condizione libro: New. New ed.. Language: English . Brand New Book. Patient self-reported data has become increasingly important in today s clinical trials. Trials in some disease indications rely upon patient recorded diary data as the primary endpoint to demonstrate drug efficacy - including, for example, indications such as insomnia, migraine and pain. In addition, improvements in quality of life measured using patient questionnaires can now be included as claims on drug labelling. Traditionally these data have been collected using paper questionnaires and diaries issued to subjects. Regulators and the industry have become increasingly aware of the limitations of recording patient reported outcomes data on paper including data quality and integrity issues. As a result there is a growing interest in collection of patient reported outcomes data using electronic means (ePRO). Solutions include handheld PDAs, Interactive Voice Response (IVR) systems, and other site-based hardware such as touchscreen PCs. Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern the community. These include: How should instruments developed on paper be adapted for electronic use, and what degree of validation should be done between paper and electronic forms? How can researchers ensure they are complying with regulatory requirements including the PRO guidance published by FDA in 2009 when using ePRO solutions? Can fewer patients be exposed in a clinical trial as a result of improved data quality obtained using electronic diaries? What type of solution should be used for certain patient populations and protocols, and how can ePRO solutions be designed optimally to increase patient acceptability and compliance? Bill Byrom and Brian Tiplady s ePro addresses all these issues, reviews the new FDA guidance, and provides a very contemporary view on this important subject. Codice libro della libreria AA69780566087714

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 110,48
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Brian Tiplady
Editore: Taylor Francis Ltd, United Kingdom (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 10
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Taylor Francis Ltd, United Kingdom, 2010. Hardback. Condizione libro: New. New ed.. Language: English . Brand New Book. Patient self-reported data has become increasingly important in today s clinical trials. Trials in some disease indications rely upon patient recorded diary data as the primary endpoint to demonstrate drug efficacy - including, for example, indications such as insomnia, migraine and pain. In addition, improvements in quality of life measured using patient questionnaires can now be included as claims on drug labelling. Traditionally these data have been collected using paper questionnaires and diaries issued to subjects. Regulators and the industry have become increasingly aware of the limitations of recording patient reported outcomes data on paper including data quality and integrity issues. As a result there is a growing interest in collection of patient reported outcomes data using electronic means (ePRO). Solutions include handheld PDAs, Interactive Voice Response (IVR) systems, and other site-based hardware such as touchscreen PCs. Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern the community. These include: How should instruments developed on paper be adapted for electronic use, and what degree of validation should be done between paper and electronic forms? How can researchers ensure they are complying with regulatory requirements including the PRO guidance published by FDA in 2009 when using ePRO solutions? Can fewer patients be exposed in a clinical trial as a result of improved data quality obtained using electronic diaries? What type of solution should be used for certain patient populations and protocols, and how can ePRO solutions be designed optimally to increase patient acceptability and compliance? Bill Byrom and Brian Tiplady s ePro addresses all these issues, reviews the new FDA guidance, and provides a very contemporary view on this important subject. Codice libro della libreria AA69780566087714

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 112,70
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Editore: Ashgate Publishing Company
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Quantità: 3
Da
Majestic Books
(London, ,, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Ashgate Publishing Company. Condizione libro: New. pp. 296 , 24 Illus. Codice libro della libreria 8122863

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 127,43
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,18
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

TIPLADY, BRIAN
Editore: Gower (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 1
Da
Herb Tandree Philosophy Books
(Stroud, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Gower, 2010. Hardback. Condizione libro: NEW. 9780566087714 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Codice libro della libreria HTANDREE01012777

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 140,04
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 8,99
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Bill Byrom, Brian Tiplady, Bill Byrom (Editor), Brian Tiplady (Editor)
Editore: Gower (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Gower, 2010. Hardcover. Condizione libro: New. 1. Codice libro della libreria DADAX0566087715

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 146,91
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,38
In U.S.A.
Destinazione, tempi e costi

9.

Byrom, Bill (Editor)/ Tiplady, Brian (Editor)
Editore: Gower Pub Co (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Rilegato Quantità: 2
Da
Revaluation Books
(Exeter, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Gower Pub Co, 2010. Hardcover. Condizione libro: Brand New. 1st edition. 257 pages. 9.75x7.00x1.00 inches. In Stock. Codice libro della libreria __0566087715

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 150,58
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,74
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Tiplady, Brian
Editore: Ashgate Pub Co (2010)
ISBN 10: 0566087715 ISBN 13: 9780566087714
Nuovi Quantità: 13
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Ashgate Pub Co, 2010. HRD. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria VT-9780566087714

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 151,65
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,38
In U.S.A.
Destinazione, tempi e costi

Vedi altre 6 copie di questo libro

Vedi tutti i risultati per questo libro